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PCLINICAL RESEARCH Myocardial Infarction
Depression Is a Risk Factor for
Mortality After Myocardial Infarction
Fact or Artifact?
Chris Dickens, PHD,* Linda McGowan, PHD,* Carol Percival, PHD,* Barbara Tomenson, MSC,*
Lawrence Cotter, MD,† Anthony Heagerty, MD,† Francis Creed, MD*
Manchester, England
Objectives This study sought to investigate the long-term impact of depression on cardiac mortality after myocardial infarc-
tion (MI) and to assess whether the timing of depression influences the findings.
Background Previous studies have shown that depression increases the risk of cardiac death after MI, although some studies
with robust methodology have failed to show this effect. Clinical trials of depression treatments have failed to
improve mortality. Until the relationship between depression and post-MI mortality is understood fully, clinical
trials aimed at reducing mortality by treating depression remain premature.
Methods We recruited 588 subjects after MI and followed up their cases for up to 8 years. Patients underwent detailed
assessments of cardiac status, conventional cardiac risk factors, and noncardiac illness at baseline. Depression
was assessed for the period immediately preceding MI and at 12 months after MI, using a standardized ques-
tionnaire and a research interview. At follow-up, the mortality status, cause, and date of death were recorded for
587 subjects using population records.
Results Multivariate predictors of cardiac death included older age (hazard ratio [HR]  1.04, p  0.007), previous an-
gina (HR  1.8, p  0.03), previous MIs (HR  1.6, p  0.004), Killip class (HR  1.8, p  0.005), beta-
blockers (HR  0.5, p  0.023), and angiotensin-converting enzyme inhibitors (HR  0.6, p  0.047) prescribed
on discharge. Depression was not associated with cardiac mortality, whether detected immediately before MI
(p  0.48), 12 months after MI (p  0.27), or at both time points (p  0.97).
Conclusions The association between depression and post-MI mortality is complex, possibly being limited to depression im-
mediately after MI. Defining the window when intervention for depression might benefit survival is crucial for the
design of future trials. (J Am Coll Cardiol 2007;49:1834–40) © 2007 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.01.075d
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mwo recent systematic reviews have shown that, in people
ith established coronary heart disease, depression predicts
n approximate 2-fold increase in all-cause mortality and
ardiac mortality (1,2). Despite the consistency of the
ndings in these reviews, it remains unclear why a number
f individual studies with robust methodologies have failed
o show an adverse effect of depression on mortality (3–7).
urthermore, psychological interventions have failed to
how a reduction in mortality, which would be expected if
epression caused an increase in mortality (8). The conflict-
ng results of previous studies may be attributable to the way
rom the *Psychological Medicine Research Group, Department of Psychiatry,
anchester University, and the †Department of Cardiology, Manchester Royal
nfirmary, Manchester, England. This study was funded by the Medical Research
ouncil, United Kingdom, and the British Heart Foundation.u
Manuscript received October 13, 2006; revised manuscript received January 22,
007, accepted January 28, 2007.epression is measured, because different measures may be
ensitive to different dimensions of depression, or duration
f follow-up (2), although variation in timing of the
ssessments and variable attempts to control for the con-
ounding effect of severity of heart disease may be respon-
ible for the heterogeneity (9). Until the causes of this
eterogeneity can be firmly established, however, the extent
o which depression increases mortality in coronary heart
isease remains uncertain (10–13).
We report here the findings of a prospective cohort study
o examine the effects of depression on cardiac mortality
fter myocardial infarction (MI). Because there is strong
vidence showing that depression is a risk factor for incident
oronary heart disease (14–16), our first assessment of
epression concerned the period immediately before MI.
he second assessment was 12 months after MI, and cardiac
ortality was assessed over a 7-year period after MI. Wesed both a semi-standardized research interview and a
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May 8, 2007:1834–40 Depression and Mortality After MIalidated questionnaire to measure depression, because type
f measure may affect the results (1,17), and we adjusted our
esults both for severity of MI and other recognized risk
actors for cardiac disease. The exceptional characteristic of
ur study was that, by using population records, we were
ble to follow up more than 99% of subjects for up to 8 years
nd obtain cause of death as recorded on death certificate.
e tested the hypothesis that depression occurring before
he MI, 12 months after MI, and at both time points would
e associated with increased mortality, after controlling for
emographic factors, conventional cardiac risks, and severity
f index MI.
ethods
ample. Consecutive patients with suspected MI admitted
o 4 inner-city hospitals between October 1997 and
ovember 1999 were screened. Subjects were included if
hey met World Health Organization criteria for MI during
heir hospital admission (18). Two of the following were
equired: 1) history of typical chest pain; 2) characteristic
lectrocardiogram changes; and 3) a serial increase in
reatine phosphokinase (CPK) to greater than twice normal
imits. Patients were excluded if they: 1) were too unwell to
omplete the assessment even with assistance from the
esearcher; 2) suffered from a serious comorbid medical
ondition; 3) were insufficiently fluent in English; 4) were
ore than 80 years of age; and 5) lived outside the catchment
reas of the hospitals used for recruitment of subjects.
aseline assessments. Suitable subjects were assessed on
verage 3.6 (standard deviation 2.1) days after the MI. We
ecorded: 1) demographic factors including age, gender,
thnicity, marital status, and years of education; 2) smoking
nd use of illegal drugs; and 3) past medical history, including
revious or family history of cardiovascular disease, and past
sychiatric history (emotional disorder treated by a general
ractitioner, psychiatrist, psychologist, or psychotherapist). So-
ioeconomic status was recorded using the criteria of Gold-
horpe and Hope (19), based on current or past employment of
ubject or partner. Severity of angina before MI was assessed
sing the Rose Angina Questionnaire (20).
Severity of the index MI was assessed using 4 measures:
. Killip class (21), a brief scale rating left ventricular
function based on the presence of pulmonary rales, S3
gallop, and peripheral hypoperfusion. High scores rep-
resent worse left ventricular function. This information
was taken from the hospital records, which were based
on the findings of physical examinations performed by a
cardiologist.
. CPK values, recorded over the 3 days after MI.
. Medication on discharge from hospital.
. Echocardiogram assessments of cardiac output were
performed on a substantial subgroup of subjects (n 
379), with cardiac outputs categorized as poor (30%),
moderate (30% to 50%), and good (50%). dBlood pressure on admission,
ny serious cardiac complications
further MI/extension of MI,
ardiac arrest) and coronary ar-
ery bypass graft (CABG) per-
ormed during index admission
ere recorded from the medical
ecords.
Social support was assessed in
erms of whether subjects had a
lose confidant, i.e., someone
ith whom the subject had reg-
lar contact (at least once per
onth) and with whom she or he
ould share sensitive personal information and gain support
3).
Anxiety and depression were assessed primarily using the
ospital Anxiety and Depression Scale (HADS) (22). At
aseline assessment subjects were instructed to complete the
ADS questionnaire to reflect their mental state in the
eek preceding the MI. Because participants were seen
sually on the third or fourth day after their MI, this
epresented 4 to 11 days before our assessment. This differs
lightly from the conventional use of the HADS, in which
ubjects are instructed to report how they have been feeling
n the 7 days immediately preceding the assessment. We
ave reported previously that individuals were able to
ifferentiate their pre-MI mood from that in the immediate
ftermath of their MI (3).
To validate the use of the HADS in this way, we adminis-
ered to 313 patients the Schedule for Clinical Assessment in
europsychiatry (23), a semistructured research interview de-
igned to assess psychiatric symptoms retrospectively. In this
ay we ascertained whether individuals met Internation Clas-
ification of Diseases (ICD)-10 criteria for depression before
heir MI. We then determined the cutoff for the HADS (total
ombined anxiety and depression score of 17 or above), which
rovided the best sensitivity (87.7%) and specificity (84.7%) to
iagnose depressive disorder (3).
We also assessed depression using the HADS question-
aire at 12 months after MI (n 440). On this occasion the
ADS was completed conventionally.
utcome. Follow-up information was obtained on 587 of
88 subjects from the Office of National Statistics. The
ain outcome for this study was cardiac mortality as
etermined from death certificate diagnoses obtained from
he Office of National Statistics.
tatistical analysis. To assess the impact of depression on
ardiac mortality, we identified individuals who fulfilled
riteria for depression before MI, 12 months after MI, and
t both times. We used these 3 measures of depression as
redictors in 3 separate analyses. Kaplan-Meier survival anal-
sis was performed and survival in depressed and nondepressed
ubjects was compared using log-rank (Mantel-Cox) analysis.
We used Cox regression to examine the association of
epression with time to cardiac death, controlling for
Abbreviations
and Acronyms
ACE  angiotensin-
converting enzyme
CABG  coronary artery
bypass graft
CI  confidence interval
CPK  creatine
phosphokinase
HADS  Hospital Anxiety
and Depression Scale
MI  myocardial infarctionemographic and medical variables. Baseline demographic
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Depression and Mortality After MI May 8, 2007:1834–40Comparison of Baseline Characteristics of PatientsWho Had Cardiac Death Versus Those Who Survived
Table 1 Comparison of Baseline Characteristics of PatientsWho Had Cardiac Death Versus Those Who Survived
Alive* Cardiac Death* p Value†
Number of subjects 449 (85%) 78 (15%)
Demographic details
Age (yrs) 58.1 (10.9) 65.6 (9.4) 0.0005
Gender
Male 315 (70.2%) 60 (76.9%) 0.28
Female 134 (29.8%) 18 (23.1%)
Ethnicity
Caucasian 422 (94.0%) 76 (97.4%) 0.58
Asian 18 (4.0%) 1 (1.3%)
Afro-Caribbean 6 (1.3%) 1 (1.3%)
Other 3 (0.7%) 0
Marital status
Single 45 (10.0%) 6 (7.7%) 0.16
Married/cohabiting 296 (65.9%) 45 (57.7%)
Widowed 57 (12.7%) 17 (21.8%)
Divorced/separated 51 (11.4%) 10 (12.8%)
Close confidant (n  507) 371 (85.7%) 59 (79.7%) 0.22
Educated to GCSE‡ or more 130 (29%) 10 (12.8%) 0.002
Job class§
Class 1–21 193 (44.7) 31 (40.8) 0.62
Class 22–35 239 (55.3) 45 (59.2)
Comorbid medical factors
Gastrointestinal problems 58 (12.9%) 8 (10.3%) 0.58
Respiratory problems 62 (13.8%) 18 (23.1%) 0.041
Joint problems 128 (28.5%) 19 (24.4%) 0.50
Illegal drug use (n  523) 22 (4.9%) 0 (0%) 0.058
Conventional coronary risks
Family history of MI (n  506) 261 (59.9%) 36 (51.4%) 0.19
History of diabetes 35 (7.8%) 16 (20.5%) 0.001
History of hypertension 131 (29.2%) 28 (35.9%) 0.23
History of angina 81 (18.0%) 36 (46.2%) 0.0005
Cholesterol on admission (n  512) 6.0 (1.3) 5.5 (1.1) 0.008
Smoking history
Never smoked 81 (18.0%) 15 (19.7%) 0.042
Current smoker 237 (52.8%) 29 (38.2%)
Past smoker 131 (29.2%) 32 (42.1%)
Number of previous MIs
0 397 (88.4%) 48 (61.5%) 0.0005
1 44 (9.8%) 19 (24.4%)
2 8 (1.8%) 6 (7.7%)
3 0 3 (3.8%)
4 0 2 (2.6%)
Previous CABG (n  237) 10 (5.3%) 9/47 (19.1%) 0.004
Severity of angina (Rose)
Moderate 49 (62.0) 23 (74.2)
Severe 30 (38.0) 8 (25.8) 0.27
Blood pressure on admission (n  512)
Diastolic 69.7 (12.8) 70.8 (13.0) 0.49
Systolic¶ 120.7 (16.3) 121.0 (20.8) 0.89
Severity of MI
Killip class  1 335 (74.8%) 31 (40.3%) 0.0005
Killip class  2 103 (23.0%) 32 (41.6%)
Killip class  3 10 (2.2%) 14 (18.2%)
Cardiac output echocardiogram
50% 151 (50.3%) 3 (7.0%) 0.0005
30% to 50% 137 (45.7%) 29 (67.4%)
30% 12 (4.0%) 11 (25.6%)
Continued on next page
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May 8, 2007:1834–40 Depression and Mortality After MInd physical variables that were significantly (p  0.05) or
early significantly (p  0.2) associated with cardiac death,
ogether with any other demographic and physical variables
hat have been associated with cardiovascular disease in
revious research, (e.g., socioeconomic status and medica-
ion on discharge) were entered as independent variables.
The following covariates were included in the regression
nalysis using forced entry: age, gender, marital status, years of
ducation, socioeconomic status, history of comorbid medical
roblems (diabetes, respiratory, abdominal, or musculoskeletal
roblems), family history of MI, number of previous MIs,
istory of prior angina or CABG, cholesterol, smoking, Killip
lass, CPK level on admission, cardiac complications during
ndex admission, thrombolysis on index admission, medication
n discharge (aspirin, beta-blockers, calcium channel blockers,
ngiotensin-converting enzyme (ACE) inhibitors, cholesterol
owering statins, diuretics). Depression or social support were
ntered in a separate block to test the significance of adding
hese variables, after adjusting for all possible confounding
ariables. We repeated the analysis 3 times, entering depression
easured at different time points (depression at baseline,
epression at 12 months, and depression that persisted from
aseline to 12 months).
For the multivariate analysis, missing values were replaced
sing mean substitution. For 2 variables the extent of missing
Continued
Table 1 Continued
CPK
1st sample (n  521)
2nd sample (n  524)
3rd sample (n  475)
Thrombolysis (n  524)
Severe cardiac complications during index admission (n 
Coronary artery bypass graft during index admission (n 
Discharge medication
Aspirin (n  510)
Beta-blockers (n  510)
Calcium channel blockers (n  510)
ACE inhibitors (n  509)
Nitrates (n  509)
Cholesterol-lowering statins (n  509)
Diuretics (n  508)
Antidepressants (n  507)
Psychosocial factors
Past psychiatric history (n  526)
Total HADS
Depressed (HADS total 17)
Hostility score (n  490)
Aggression score (n  489)
*Figures presented are either mean (standard deviation) for continu
presented on the total sample of 527 subjects who were alive at final f
of subjects on whom data were included in analysis is detailed in pare
exact test, or t test, as appropriate. ‡GCSE refers to General Certificate o
reflects higher socioeconomic status, 22–35 reflects lower status. ¶Un
Mann-Whitney U test in view of degree of nonnormality of distributio
sample).
ACE  angiotensin-converting enzyme; CABG  coronary artery by
Depression Scale; MI  myocardial infarction.ata was substantial (history of CABG before MI, n  237; deft ventricular ejection fraction, n  379). These variables
ere excluded from the main analysis, although subsequent
nalyses showed that the result for depression was stable
hether these variables were included with mean substitution
r whether the analysis was limited to those subjects for whom
omplete data on this item were recorded. For brevity only the
esults with these variables excluded are presented.
This study complied with the Declaration of Helsinki.
ull ethical permission was granted by Local Research
thical Committees (ethics application numbers: NOR/98/
21, CM/97/090, 98090).
esults
he baseline characteristics of our subjects have been
eported previously (3), so only the main features of our
ample are reported here.
Of the 654 subjects that fulfilled our inclusion and
xclusion criteria, 588 (90%) subjects completed baseline
ssessments. The mean age of the sample was 60.0 years
SD  11.1); 414 (70.4%) were male. Four hundred and
inety-two subjects (84%) were admitted after their first
I, 74 with their second, 17 with their third, 3 with their
ourth, and 2 with their fifth; 140 (23.8%) had depressive
Alive* Cardiac Death* p Value†
593 (923) 618 (749) 0.83
1,240 (1,213) 1,356 (1,271) 0.44
927 (1,099) 1,073 (1,424) 0.32
331 (73.9%) 47 (61.8%) 0.018
) 32 (12.3%) 9 (15.5%) 0.52
9 (2.0%) 1 (1.3%) 1.0
423 (95.7%) 61 (89.7%) 0.067
286 (64.7%) 21 (30.9%) 0.0005
85 (19.2%) 18 (26.5%) 0.19
186 (42.2%) 36 (52.9%) 0.12
273 (61.9%) 43 (63.2%) 0.89
335 (76%) 44 (64.7%) 0.053
65 (14.8%) 31 (45.6%) 0.0005
19 (4.3%) 2 (2.9%) 1.0
160 (35.6%) 24 (31.2%) 0.52
10.9 (7.9) 11.2 (7.4) 0.79
108 (24.1) 17 (21.8) 0.77
1.82 (1.3) 1.83 (1.3) 0.96
4.0 (1.9) 4.0 (2.0) 0.88
iables or number of subjects (%) for categorical variables. Data are
p or who had died of cardiac causes. Where data are missing, number
s after the variable names. †Significance from chi-square test, Fisher
dary Education (equivalent to 12 years of education). §Job class 1–21
ariance version of the t test was used. Comparisons made using the
riables; p  0.052 (1st sample), 0.64 (2nd sample), and 0.68 (3rd
raft; CPK  creatine phosphokinase; HADS  Hospital Anxiety and318
520)
ous var
ollow-u
nthese
f Secon
equal v
n of vaisorder (HADS score 17).
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Depression and Mortality After MI May 8, 2007:1834–40Of the 588 completing baseline assessments, 587 were
raced at follow-up. Mean duration of follow-up was 6.75
ears (range 6 to 8 years). Of the 587 on whom survival data
ere available, 78 (13.3%) subjects had suffered death
aused by cardiac cause; 60 (10.2%) subjects had died of a
oncardiac cause.
Comparison of the 78 subjects dying of cardiac causes
ith 449 subjects alive at the time of final assessment is
resented in Table 1. Mortality was associated with subjects’
ge, educational status, presence of comorbid respiratory
roblems, diabetes, previous cardiovascular disease (angina,
I, or CABG), history of smoking, high cholesterol, more
evere MI (high Killip class or low left ventricular ejection
raction), whether thrombolysis was used, and drugs prescribed
n discharge from hospital (beta-blockers and diuretics).
There was no significant difference in survival between
hose with depression (HADS total score 17) in the week
receding MI (mean survival 89.2 months, 95% confidence
nterval [CI] 84.7 to 93.8) and those without (mean survival
9.9 months, 95% CI 87.4 to 92.4, log rank [Mantel-Cox]
hi-square 0.10, p  0.75) (Fig. 1).
For the subgroup (n  313) of subjects undergoing the
emistandardized research interview, those diagnosed as
epressed (ICD-10 criteria) showed similar survival to those
ho were not depressed (mean survivals 95.4 months [95%
I 91.2 to 99.6] and 92.0 months [95% CI 89.1 to 95.0],
espectively, log rank p  0.12). Those without a close
onfidant showed similar mortality to those who reported
aving a confidant (mean survival 85.3 months [95% CI
8.7 to 91.9] and 90.8 months [95% CI 88.5 to 93.1],
espectively, log rank p  0.15).
For the subgroup who returned HADS postal assess-
ents at 12 months (n  440, 81% of those alive at 12
onths), depressed subjects showed no difference in survival
ompared with the nondepressed (mean survival 94.1
onths [95% CI 91.0 to 97.2] and 96.3 [95% CI 94.7 to
7.9], respectively, log rank p  0.66). Among the 53
atients who were depressed at both baseline and 12 months
HADS total score 17) there were no cardiac-related
eaths during the following 6 years, compared with 32
ardiac deaths in the 387 nondepressed patients (8.3%).
hose depressed at baseline and at 12 months had signifi-
antly better survival than those who were not depressed
log rank p  0.031).
On Cox regression, predictors of mortality during the
ollow-up period were older age, history of angina, number
f previous MIs, and Killip class after index MI. Predictors
f survival were whether individuals were prescribed beta-
lockers or ACE inhibitors on discharge (Table 2).
Depression failed to contribute to this model whether
ases of depression were defined using HADS score 17
n  587, p  0.48), ICD criteria (n  313, p  0.09)*,
epression at 12-month follow-up (HADS 17; n  440,s
Regression coefficient  1.1 indicating a trend for ICD-10 depression to protect
gainst cardiac mortality. 0.27), or depression at both baseline and 12 months
n  440, p  0.97). Furthermore, having a close confidant
ailed to predict survival (n  587, p  0.51), and there was
o significant interaction between having a close confidant
nd HADS depression (p  0.49).
A retrospective power calculation showed that, given our
opulation size and the prevalence of depression, our study
ad 80% power to detect a hazard ratio of 1.42 at the level
f significance p  0.05. This would equate to a mortality
ate of 24.5% in the depressed if the mortality rate in the
ondepressed remained the same (13.6%).
iscussion
n a fairly large cohort of people admitted to the hospital after
I, we did not find that depression predicted a subsequent
ncrease in cardiac mortality, whether we considered depression
efore MI, depression 12 months after MI, or depression that
as present at both times. Cardiac mortality was predicted by
reater age, history of angina and previous MI, and cardiac
ailure during admission. Survival was predicted by prescription
f beta-blockers and ACE inhibitors on discharge.
The major strength of our study was our ability to trace 587
f the original 588 subjects for up to 8 years after MI and to
btain details of cause of death. We assessed accurately
epression at 2 time points and analyzed separately those who
ere depressed at both times. We were able also to adjust for
wide range of psychosocial factors and the cardiac status of
ur patients after their MI. The major weakness relates to
omparison with other studies—we did not measure depres-
Figure 1 Survival Functions
Survival curves for depressed and nondepressed patients (Hospital Anxiety and
Depression Scale [HADS] total score 17 in the week before myocardial infarc-
tion). Cum  cumulative.ion in the weeks immediately after MI as others have done.
f
n
s
r
a
M
i
d
t
c
f
t
M
p
d
t
i
a
a
o
fl
a
t
p
a
a
m
O
s
o
b
w
2
c
c
(
b
i
t
m
m
o
t
i
t
(
e
t
l
o
a
i
c
c
a
M
t
i
t
d
p
a
l
M
d
m
o
l
c
b
b
p
t
i
s
l
m
a
w
r
1839JACC Vol. 49, No. 18, 2007 Dickens et al.
May 8, 2007:1834–40 Depression and Mortality After MIOur findings, that depression is not an independent risk
actor for cardiac mortality after MI, differ from those of a
umber of other studies (1,2). Although this difference in
tudy findings could be explained by the fact that we
ecorded depression immediately before and/or 12 months
fter MI but did not assess depression immediately after
I, some other studies that have recorded depression
mmediately after MI have still failed to detect an effect of
epression on mortality (4–7). This suggests that, although
iming of the depression assessment may have been a
ontributory factor in explaining why our findings differed
rom those of other studies, it does not explain completely
he heterogeneity of findings in this research overall.
We chose to measure depression immediately preceding
I because there is good evidence showing that depression
receding MI is associated with incident coronary heart
isease (14–16) and cardiac death (24–26). We assumed
hat depression present before the MI, especially that which
s chronic, would be a risk factor for poor outcome after MI
lso, because it is associated with persistent social difficulties
nd heavy smoking (27,28). In addition, our patients were
nly in the hospital a few days and we did not regard the
uctuating distress reported by patients immediately after
n MI as true depressive disorder (28). Such distress is
ransient in many (28,29), whereas we were interested in the
ersisting symptoms of depressed mood associated with
ltered patterns of sleep, appetite, and concentration that
mounted to depressive illness, which we assumed would be
ore likely to be associated with cardiac problems (26,30).
ur patients had no difficulty reporting these depressive
ymptoms for the week preceding MI. Although our meth-
ds have highlighted the complexities in the association
etween depression and outcome after MI, in retrospect it
ould have been useful to have recorded depression for the
to 4 weeks immediately after MI also, to facilitate
omparison of our study with others.
Our negative finding for depression preceding MI is
onsistent with the only other study, by Lesperance et al.
31), to have measured depression in the period immediately
efore MI and examined its impact on subsequent mortal-
ty. Unlike another study by the same group, we did not find
hat depression 12 months after MI predicted subsequent
Cox Regression Investigating Predictors of Surv
Table 2 Cox Regression Investigating Predi
Regression
Coefficient (SE)
Age 0.04 (0.015)
Pre-MI angina 0.59 (0.28)
Number of previous MIs 0.48 (0.17)
Killip class 0.57 (0.20)
Beta-blockers on discharge 0.66 (0.29)
ACE inhibitors on discharge 0.55 (0.28)
HADS score 17 0.22 (0.31)
CI  confidence interval; other abbreviations as in Table 1.ortality, although the impact of 12-month depression on aortality in the Lesperance study did become nonsignificant
nce the effects of baseline depression were controlled (32).
It remains possible that it is depressive disorder or even
ransient depressive symptoms (i.e., acute distress) developing
n the immediate post-MI period that are particularly cardio-
oxic (33). Such acute distress is a recognized precipitant of MI
34), and thus is a likely risk factor of further acute coronary
vents after MI, possibly because of its effect on autonomic
one at a time when the myocardium is very sensitive, thus
eading to arrhythmias (35). This would be consistent with the
bservation that post-MI depressive symptoms in the days
fter MI are particularly associated with sudden death in
ndividuals showing a high number of premature ventricular
ontractions, suggesting that arrhythmias are the most likely
ause of death (17). If the relationship between depression
nd mortality is confined to depression immediately after
I, then this has important implications for intervention
rials; for example, the ENRICHD (Enhancing Recovery
n Coronary Heart Disease Patients) trial recruited pa-
ients within 28 days after their MI.
Despite our negative finding, we do not conclude that
epression before and after MI is unimportant. We have
reviously shown that depression around the time of MI is
potent predictor of impairment in health-related quality of
ife (36). Because mortality is declining as an outcome after
I and there is a trend for a reduction in the effect of
epression on mortality (2), future intervention studies
ight wish to consider quality of life as their primary
utcome. Studies will be smaller in size, and findings are
ikely to generalizable to a greater proportion of people with
oronary heart disease.
Our findings highlight the complexity of the association
etween depression and coronary heart disease. One possi-
le reason for this is the suggestion that depression leads to
oor outcome through different mechanisms at different
imes (34). On the one hand, depression is associated with
ncident heart disease after controlling for other risk factors
uch as smoking (in otherwise healthy individuals). The
atency of this effect seems to be years rather than weeks or
onths, suggesting that depression plays a part in increased
therogenesis through physiological and/or behavioral path-
ays; this effect is possibly greater in those who have
eceived treatment for depression (37,38). Depression and
fter MI
of Survival After MI
p Value Hazard Ratio
95% CI for
Hazard Ratio
0.007 1.04 1.01–1.07
0.033 1.81 1.05–3.13
0.004 1.61 1.17–2.23
0.005 1.76 1.18–2.62
0.023 0.52 0.29–0.91
0.047 0.58 0.34–0.99
0.48 0.81 0.44–1.47ival A
ctorscute distress in the period immediately after MI appear to
b
c
g
O
d
w
l
a
t
s
c
b
t
g
i
A
T
c
R
p
I
E
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
1840 Dickens et al. JACC Vol. 49, No. 18, 2007
Depression and Mortality After MI May 8, 2007:1834–40e associated with cardiac mortality, although the time
ourse is much shorter (weeks to months) and the risks are
reatest in those with high risks of arrhythmias (17).
utside this immediate post-MI period, the adverse impact of
epression diminishes. It is likely that the risks of arrhythmia
ill be lower once the myocardium has recovered and that any
ong-term pro-atheromatous effects of depression are moder-
ted by treatments for the heart disease.
Future observational studies should consider carefully the
iming of onset of depression and whether any specific
ymptoms or dimensions of depression are particularly
ardiotoxic to identify subgroups that are most likely to
enefit from treatment. The importance of understanding
hese relationships more exactly lies in the need to design with
reater precision further intervention studies to test whether
mproved depression leads to reduced mortality (29).
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